Myofunctional Therapy in Facial Palsy

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin injection in patients with long standing facial unilateral palsy.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo General Hospital
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• facial paralysis with more than 2 years elapsed since the onset of symptoms

• surgically treated for reanimation at least 12 months before

• static and/or dynamic facial asymmetry causing aesthetic concern

Exclusion Criteria:

• spastic paralysis

• serious systemic or neuromuscular diseases

• cognition impairment

• pregnant women